Prof. Wei ChenTaiwan
Genomics Research Center, Academia Sinica
| 2023/11 to present | | Assistant Research Fellow / Assistant Professor, Genomics Research Center, Academia Sinica |
| 2020 - 2023 | | Postdoctoral Research Fellow, Center for Nanomedicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA |
| 2014/09 - 2019/09 | | Ph.D., Department of Chemistry and Biochemistry, University of California Los Angeles (UCLA), Los Angeles, CA, USA |
| 2009/09 - 2011/07 | | M.S., Department of Chemistry, National Taiwan University, Taipei, Taiwan |
| 2005/09 - 2009/06 | | B.S., Department of Chemistry, National Taiwan University, Taipei, Taiwan |
| 2025 | | Moderna Taiwan mRNA Innovation Awards, Biomedical Translational Research Center, Academic Sinica - Moderna Taiwan, Taiwan |
| 2024 | | Royal Society of Chemistry, Nanoscale Emerging Investigator Award, UK |
| 2024 | | "Dr. Yun MOU" Outstanding Young Scholar Award, Taiwan Nanomedicine Society, Taiwan |
Nanomedicine, Biomedical engineering, Drug delivery technology, Biomaterials, Nanotechnology, RNA medicine
I am a materials chemistry, nanomedicine, and biomedical engineering investigator with a multidisciplinary background in Nanomedicine, Drug Delivery, Chemistry, Materials Science, Biomedical Engineering, Nanotechnology, and Biology. My research thrusts encompass both the innovation of fundamental materials (such as nanoparticles, two-dimensional materials, hydrogels, and RNA nanomedicine) and living materials (such as engineered microalgae, microbes, and cells) and their diverse applications in disease treatment, and translational medicine. These innovations are designed to facilitate the efficient delivery of therapeutics to lesion areas for the treatment of various diseases, including cancer, atherosclerotic cardiovascular disease and other inflammatory diseases.
Intelligent Biomaterials-Enabled Drug Delivery and Precision Cell Engineering for Disease Therapy
TBA TBA
Biomedical Materials and Precision Medicine/TBA
Intelligent biomaterials and nanomedicine have attracted much attention in recent decades for disease treatments. Notably, these advancements in cardiovascular disease, cancer, and inflammatory disease treatments hold significant promise for addressing unmet medical needs. The first section of the presentation will focus on the utilization of macrophage-modulating nano-biologics and siRNA/mRNA medicine for precision immune engineering and atherosclerotic cardiovascular disease immunotherapy. The second section of the presentation will highlight the biomedical applications of intelligent nanomaterials in innovative cancer immunotherapy as well as anti-aging technologies.